Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Viemed Healthcare Inc VMD

Viemed Healthcare, Inc. through its subsidiaries, is a provider of home medical equipment (HME) and post-acute respiratory healthcare services in the United States. The Company’s service offerings are focused on effective in-home treatment with clinical practitioners providing therapy and counselling to patients in their homes using cutting edge technologies. The Company’s products and services include Home Medical Equipment, In-home sleep testing, and Healthcare staffing. Home Medical Equipment provides respiratory and other home medical equipment, including home ventilation, bi-level positive airway pressure (BiPAP) and continuous positive airway pressure (CPAP) devices, percussion vests, and other medical equipment. In-home sleep testing provides in home sleep apnea testing services. Healthcare staffing provides healthcare staffing and recruitment services. The Company provides home medical equipment services through its interest in East Alabama HomeMed, LLC (HomeMed).


NDAQ:VMD - Post by User

Post by donmayneon Feb 03, 2022 12:12pm
149 Views
Post# 34393506

Patient count increase

Patient count increaseTheir Feb 2022 investor presentation deck states "over 35,000 patients".  The August 2021 through to January 2022 investor presentation decks were all at "over 30,000 patients."  The July 2021 deck had "over 27,000 patients."

This suggests an average increase of 5000/7 or 714 each month during the last 6 months.  

The average monthly client revenue is stated in the February deck as $950/mo which translates to $678,000 added to core business revenues each month or roughly a 30% per annum growth rate on core revenues.  

The last six months were all in the midst of the pandemic so a go forward growth rate will likely suggest something higher than 30% revenue growth.  

If this is properly articulated, it could easily trigger an expansion of their P/E multiple.  

<< Previous
Bullboard Posts
Next >>